Cargando…

Impact of rs2414096 polymorphism of CYP19 gene on susceptibility of polycystic ovary syndrome and hyperandrogenism in Kashmiri women

Polycystic ovary syndrome (PCOS) is the most common reproductive endocrine disorder in pre-menopausal women having complex pathophysiology. Several candidate genes have been shown to have association with PCOS. CYP19 gene encodes a key steroidogenic enzyme involved in conversion of androgens into es...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ashraf, Sairish, Rasool, Shayaq Ul Abeer, Nabi, Mudasar, Ganie, Mohd Ashraf, Masoodi, Shariq R., Amin, Shajrul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217560/ https://www.ncbi.nlm.nih.gov/pubmed/34155264 http://dx.doi.org/10.1038/s41598-021-92265-1

Ejemplares similares

Insulin Receptor Substrate 1 Gly972Arg (rs1801278) Polymorphism Is Associated with Obesity and Insulin Resistance in Kashmiri Women with Polycystic Ovary Syndrome
por: Rasool, Shayaq Ul Abeer, et al.
Publicado: (2022)

Clinical Manifestations of Hyperandrogenism and Ovulatory Dysfunction Are Not Associated with His1058 C/T SNP (rs1799817) Polymorphism of Insulin Receptor Gene Tyrosine Kinase Domain in Kashmiri Women with PCOS
por: Rasool, Shayaq Ul Abeer, et al.
Publicado: (2021)

Association between CYP19 gene SNP rs2414096 Polymorphism and polycystic ovary syndrome in Chinese women
por: Jin, Jia-Li, et al.
Publicado: (2009)

Association of SNP rs.2414096 CYP19 gene with polycystic ovarian syndrome in Iranian women
por: Mehdizadeh, Anahita, et al.
Publicado: (2017)

Bifidobacterium Is Enriched in Gut Microbiome of Kashmiri Women with Polycystic Ovary Syndrome
por: Hassan, Saqib, et al.
Publicado: (2022)

The Lys469glu/K469E Polymorphism of the Inflammatory Gene Intercellular Adhesion Molecule-1 Lacks any Apparent Role in the Polycystic Ovary Syndrome in Kashmiri Women: A Case Control Study
por: Yousuf, Syed Douhath, et al.
Publicado: (2017)

Fibroscan as a non-invasive predictor of hepatic steatosis in women with polycystic ovary syndrome
por: Chakraborty, Semanti, et al.
Publicado: (2020)

Association of -675 4G/5G PAI-1 and -2518A/G MCP-1 genetic polymorphisms with polycystic ovary syndrome in Kashmiri women: A case control study
por: Yousuf, Syed Douhath, et al.
Publicado: (2022)

The Relationship Between Hearing Thresholds and Hyperandrogenism in Polycystic Ovary Syndrome
por: Turan, Mahfuz, et al.
Publicado: (2016)

Hyperandrogenism correlates with psychological symptoms in adolescents with polycystic ovary syndrome
por: Donbaloğlu, Zeynep, et al.
Publicado: (2022)

In Vitro Antioxidant and Cytotoxic Activities of Arnebia benthamii (Wall ex. G. Don): A Critically Endangered Medicinal Plant of Kashmir Valley
por: Ganie, Showkat Ahmad, et al.
Publicado: (2014)

Identification of Differentially Expressed MicroRNAs in the Ovary of Polycystic Ovary Syndrome with Hyperandrogenism and Insulin Resistance
por: Lin, Lin, et al.
Publicado: (2015)

Metformin Therapy Decreases Hyperandrogenism and Ovarian Volume in Women with Polycystic Ovary Syndrome
por: Farimani Sanoee, Marzieh, et al.
Publicado: (2011)

Ovarian Aging-Like Phenotype in the Hyperandrogenism-Induced Murine Model of Polycystic Ovary
por: Rezvanfar, Mohammad Amin, et al.
Publicado: (2014)

Are Psychosocial Consequences of Obesity and Hyperandrogenism Present in Adolescent Girls with Polycystic Ovary Syndrome?
por: Zachurzok, Agnieszka, et al.
Publicado: (2018)

Telomere Length Differently Associated to Obesity and Hyperandrogenism in Women With Polycystic Ovary Syndrome
por: Velazquez, Mariela Edith, et al.
Publicado: (2021)

Cross sectional study on Kashmiri tribal population: Their demo-economic status and behavioural risk factors
por: Ganie, Mohd Ashraf, et al.
Publicado: (2020)

Effect of six-month use of oral contraceptive pills on plasminogen activator inhibitor-1 & factor VIII among women with polycystic ovary syndrome: An observational pilot study
por: Yousuf, Syed Douhath, et al.
Publicado: (2018)

Prevalence of ultrasonography proved polycystic ovaries in North Indian women with type 2 diabetes mellitus
por: Zargar, Abdul H, et al.
Publicado: (2005)

Idiopathic Hyperprolactinemia Presenting as Polycystic Ovary Syndrome in Identical Twin Sisters: A Case Report and Literature Review
por: Goyal, Alpesh, et al.
Publicado: (2018)

Pattern of urinary albumin excretion in normotensive young and adolescent Indian women with polycystic ovary syndrome
por: Ganie, Mohd Ashraf, et al.
Publicado: (2012)

Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: a meta-analysis
por: Yang, Rui, et al.
Publicado: (2016)

Correlation between biochemical and clinical hyperandrogenism parameter in polycystic ovary syndrome in relation to age
por: Guo, Zaixin, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease is associated with hyperandrogenism in women with polycystic ovary syndrome
por: Hong, So-hyeon, et al.
Publicado: (2023)

Adiponectin and Its Receptors in the Ovary: Further Evidence for a Link between Obesity and Hyperandrogenism in Polycystic Ovary Syndrome
por: Comim, Fabio V., et al.
Publicado: (2013)

Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India
por: Ganie, Mohammad Ashraf, et al.
Publicado: (2019)

Polycystic ovary syndrome – A metabolic malady, the mother of all lifestyle disorders in women – Can Indian health budget tackle it in future?
por: Ganie, M. Ashraf, et al.
Publicado: (2011)

Quantitative Changes in White Blood Cells: Correlation with the Hallmarks of Polycystic Ovary Syndrome
por: Almaeen, Abdulrahman H., et al.
Publicado: (2022)

Follicular hyperandrogenism and insulin resistance in polycystic ovary syndrome patients with normal circulating testosterone levels
por: Li, Andi, et al.
Publicado: (2018)

Effect of “DXB-2030,” a Polyherbal Formulation, on Experimental Polycystic Ovary Syndrome Associated with Hyperandrogenism
por: Azeemuddin, Mohammed, et al.
Publicado: (2019)

Serum calprotectin levels as markers of inflammation, insulin resistance and hyperandrogenism in women with polycystic ovary syndrome
por: Hancerliogullari, Necati, et al.
Publicado: (2022)

Vitamin D status among Kashmiri tribal population: A cross-sectional community-based study
por: Ganie, Mohd Ashraf, et al.
Publicado: (2022)

Cardiovascular disease risk in women with hyperandrogenism, oligomenorrhea/menstrual irregularity or polycystic ovaries (components of polycystic ovary syndrome): a systematic review and meta-analysis
por: Lo, Andre C Q, et al.
Publicado: (2023)

Prevalence of metabolic syndrome in the family members of women with polycystic ovary syndrome from North India
por: Shabir, Iram, et al.
Publicado: (2014)

Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review
por: Paixão, Larissa, et al.
Publicado: (2017)

Hyperandrogenism and Metabolic Syndrome Are Associated With Changes in Serum-Derived microRNAs in Women With Polycystic Ovary Syndrome
por: Sørensen, Anja E., et al.
Publicado: (2019)

Effect of DHT-Induced Hyperandrogenism on the Pro-Inflammatory Cytokines in a Rat Model of Polycystic Ovary Morphology
por: Krishnan, Abhaya, et al.
Publicado: (2020)

Elevated plasma pentraxin-3 in polycystic ovary syndrome is associated with hyperandrogenism: a case-control study
por: Jin, Congcong, et al.
Publicado: (2021)

Cardiovascular, anthropometric, metabolic and hormonal profiling of normotensive women with polycystic ovary syndrome with and without biochemical hyperandrogenism
por: Kałużna, Małgorzata, et al.
Publicado: (2021)

The impact of hyperandrogenism on the outcomes of ovulation induction using gonadotropin and intrauterine insemination in women with polycystic ovary syndrome
por: Ho, Vu Ngoc Anh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lj7vjbbodsl1jbcdn1f2sndf6b